[go: up one dir, main page]

MX2014014322A - Oxidized regenerated cellulose hemostatic powders and methods of making. - Google Patents

Oxidized regenerated cellulose hemostatic powders and methods of making.

Info

Publication number
MX2014014322A
MX2014014322A MX2014014322A MX2014014322A MX2014014322A MX 2014014322 A MX2014014322 A MX 2014014322A MX 2014014322 A MX2014014322 A MX 2014014322A MX 2014014322 A MX2014014322 A MX 2014014322A MX 2014014322 A MX2014014322 A MX 2014014322A
Authority
MX
Mexico
Prior art keywords
making
methods
regenerated cellulose
oxidized regenerated
hemostatic powders
Prior art date
Application number
MX2014014322A
Other languages
Spanish (es)
Other versions
MX354596B (en
Inventor
Yi-Lan Wang
Guanghui Zhang
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48537032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014014322(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of MX2014014322A publication Critical patent/MX2014014322A/en
Publication of MX354596B publication Critical patent/MX354596B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C08L1/04—Oxycellulose; Hydrocellulose, e.g. microcrystalline cellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Surgical Instruments (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention is directed to hemostatic material containing compacted ORC powder comprising particles having an average aspect ratio from about 1 to about 18, wherein said compacted ORC powder have preferably been processed in a compaction device, such as a ball milled ORC powder. The present invention further relates to methods of making the hemostatic material and a method of treating a wound by applying the hemostatic powder onto and/or into the wound of a patient.
MX2014014322A 2012-05-25 2013-05-22 Oxidized regenerated cellulose hemostatic powders and methods of making. MX354596B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/480,842 US8815832B2 (en) 2012-05-25 2012-05-25 Oxidized regenerated cellulose hemostatic powders and methods of making
PCT/US2013/042149 WO2013177242A1 (en) 2012-05-25 2013-05-22 Oxidized regenerated cellulose hemostatic powders and methods of making

Publications (2)

Publication Number Publication Date
MX2014014322A true MX2014014322A (en) 2015-02-12
MX354596B MX354596B (en) 2018-03-12

Family

ID=48537032

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018003025A MX358625B (en) 2012-05-25 2013-05-22 Oxidized regenerated cellulose hemostatic powders and methods of making.
MX2014014322A MX354596B (en) 2012-05-25 2013-05-22 Oxidized regenerated cellulose hemostatic powders and methods of making.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018003025A MX358625B (en) 2012-05-25 2013-05-22 Oxidized regenerated cellulose hemostatic powders and methods of making.

Country Status (16)

Country Link
US (2) US8815832B2 (en)
EP (3) EP4043042A1 (en)
JP (1) JP6165849B2 (en)
KR (2) KR102254305B1 (en)
CN (1) CN104321085B (en)
AU (1) AU2013266416B2 (en)
BR (2) BR112014029206B1 (en)
CA (2) CA3094664C (en)
DK (1) DK3466455T3 (en)
ES (2) ES2906971T3 (en)
IL (2) IL235549B (en)
IN (1) IN2014DN09514A (en)
MX (2) MX358625B (en)
RU (2) RU2696575C2 (en)
WO (1) WO2013177242A1 (en)
ZA (1) ZA201409429B (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102844053B (en) 2009-11-25 2015-08-05 洛马林达大学医学中心 Based on the hemostatic textile of chitosan
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
BR112017000844B1 (en) * 2014-07-18 2020-12-15 Ethicon, Inc COMPOSITE MATERIAL OF CARBOXIMETHY CELLULOSE AND METHOD FOR THE MANUFACTURE AND USE OF THE SAME
US10183132B2 (en) 2014-09-11 2019-01-22 Ethicon Llc Methods and devices for co-delivery of liquid and powdered hemostats and sealants
CA3004272C (en) 2015-11-06 2023-11-07 Ethicon, Inc. Compacted hemostatic cellulosic aggregates
ES2886040T3 (en) 2015-11-08 2021-12-16 Omrix Biopharmaceuticals Ltd Cellulose-based short and long fiber hemostatic mixture
RU2741304C2 (en) * 2015-11-08 2021-01-25 Омрикс Биофармасьютикалс Лтд. Haemostatic composition
US11413335B2 (en) * 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
CN107754005B (en) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 Hemostatic compositions and methods of making same
US20220111020A1 (en) * 2016-08-15 2022-04-14 Guangzhou Bioseal Biotech Co. Ltd. Hemostatic compositions and methods of making thereof
KR102656226B1 (en) * 2016-12-09 2024-04-09 한국생산기술연구원 Hemostatic material comprising calcium carboxymethyl cellulose powder and water-soluble chitosan compound powder and process for preparing the same
RU2660582C1 (en) * 2017-07-12 2018-07-06 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) Hemostatic coating in the form of powder
US11679177B2 (en) 2017-08-08 2023-06-20 Baxter International Inc. Polymeric compositions, delivery devices, and methods
US11007299B2 (en) 2017-11-08 2021-05-18 Ethicon, Inc. Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery
ES2968412T3 (en) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Method for preparing a hemostatic composition
IL262716A (en) * 2018-11-01 2018-11-29 Omrix Biopharmaceuticals Ltd Oxidized cellulose compositions
US11241386B2 (en) * 2019-02-13 2022-02-08 Biolife, L.L.C. Wound sealing powder
CA3144277A1 (en) * 2019-06-26 2020-12-30 Davol Inc. Reactive dry powdered hemostatic materials comprising a nucleophile and a multifunctional modified polyethylene glycol based crosslinking agent
ES2961107T3 (en) 2019-07-12 2024-03-08 Cilag Gmbh Int hemostatic powder
EP3996760B1 (en) 2019-07-12 2023-08-09 Cilag GmbH International Method for preparing a tissue-adhesive sheet
CN114096286B (en) 2019-07-12 2023-06-02 加特技术公司 Biocompatible flexible hemostatic tablet
WO2021014357A1 (en) * 2019-07-23 2021-01-28 Kci Licensing, Inc. Collagen-based biomaterials for wound management
IL268572A (en) * 2019-08-07 2019-09-26 Omrix Biopharmaceuticals Ltd Expandable hemostat composed of oxidized cellulose
US20210106717A1 (en) * 2019-10-10 2021-04-15 Cook Medical Technologies Llc Bonded powders for the treatment of bodily lesions
KR102886728B1 (en) * 2019-10-31 2025-11-14 주식회사 삼양홀딩스 Powder type hemostatic composition and method for preparing the same
CN113117133B (en) * 2019-12-31 2023-03-14 广州迈普再生医学科技股份有限公司 Fiber aggregate and preparation method and application thereof
CN113117131B (en) * 2019-12-31 2023-01-03 广州迈普再生医学科技股份有限公司 Nanofiber microsphere material and preparation method and application thereof
CN113117132B (en) * 2019-12-31 2022-11-22 广州迈普再生医学科技股份有限公司 Absorbable expansion type nano short fiber powdery material and preparation method and application thereof
US12285539B2 (en) * 2020-04-17 2025-04-29 Boston Scientific Scimed, Inc. Hemostatic compositions and related methods
RU2756316C1 (en) * 2020-06-15 2021-09-29 Федеральное государственное бюджетное учреждение науки Байкальский институт природопользования Сибирского отделения Российской академии наук (БИП СО РАН) Local hemostatic antibacterial agent, method for production thereof, and medical product based thereon
US12285540B2 (en) 2020-07-21 2025-04-29 Ethicon, Inc. Hemostatic composite aggregate materials having surface enriched with hemostatis-promoting agents
CN114681660B (en) * 2020-12-31 2023-04-18 广州迈普再生医学科技股份有限公司 Absorbable styptic powder and preparation method and application thereof
CA3207273A1 (en) 2021-01-08 2022-07-14 Cilag Gmbh International Bioresorbable sealing powder
US20240148933A1 (en) 2022-11-08 2024-05-09 Ethicon, Inc. Expandable hemostatic tablets comprising oxidized regenerated cellulose
GB2636872A (en) * 2023-12-29 2025-07-02 Futamura Chemical Uk Ltd Composition
US20250262343A1 (en) * 2024-02-21 2025-08-21 Solomon Rosenblatt Polymeric iodophor compositions and methods of use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364200A (en) 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
US5696191A (en) 1989-09-18 1997-12-09 Kimberly-Clark Worldwide, Inc. Surface-segregatable compositions and nonwoven webs prepared therefrom
US5180398A (en) 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
JP3287798B2 (en) 1997-12-17 2002-06-04 レンゴー株式会社 Method for producing spherical cellulose fine particles
RU2146264C1 (en) * 1998-08-10 2000-03-10 Институт эколого-технологических проблем Method of preparing highly oxidized cellulose and highly oxidized cellulose "bioaktsellin"
GB2354708B (en) 1999-10-01 2004-06-02 Johnson & Johnson Medical Ltd Compositions for the treatment of wound contracture
US6627749B1 (en) 1999-11-12 2003-09-30 University Of Iowa Research Foundation Powdered oxidized cellulose
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
US6652840B1 (en) 2001-02-21 2003-11-25 Terence Prevendar Bleeding control and healing aid compositions and methods of use
US20030124087A1 (en) 2001-12-26 2003-07-03 Amitie Co. Ltd. Anti-adhesion barrier
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
GB2393120A (en) 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
ATE475434T1 (en) 2004-01-30 2010-08-15 Ferrosan As HEMOSTATIC SPRAYS AND COMPOSITIONS
US20070141156A1 (en) * 2005-12-21 2007-06-21 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
US20080027365A1 (en) 2006-06-01 2008-01-31 Huey Raymond J Hemostatic device with oxidized cellulose pad
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
JP5031054B2 (en) * 2010-03-18 2012-09-19 信越化学工業株式会社 Low substituted hydroxypropyl cellulose and solid preparation containing the same
US10022410B2 (en) 2010-12-22 2018-07-17 Ethicon, Inc. Hemostatic preparation containing an extract of golden moss
CN103797182B (en) 2011-09-12 2016-05-04 郡是株式会社 The manufacture method of hydrophiling cellulose fibre
US9028851B2 (en) 2011-12-21 2015-05-12 Ethicon, Inc. Hemostatic materials and devices with galvanic particulates
BR112017000844B1 (en) 2014-07-18 2020-12-15 Ethicon, Inc COMPOSITE MATERIAL OF CARBOXIMETHY CELLULOSE AND METHOD FOR THE MANUFACTURE AND USE OF THE SAME
CA3004272C (en) 2015-11-06 2023-11-07 Ethicon, Inc. Compacted hemostatic cellulosic aggregates

Also Published As

Publication number Publication date
ZA201409429B (en) 2017-04-26
ES2906971T3 (en) 2022-04-21
EP2854882A1 (en) 2015-04-08
IN2014DN09514A (en) 2015-07-17
BR112014029206A2 (en) 2017-06-27
MX358625B (en) 2018-08-28
CA3094664C (en) 2023-06-06
CA2874622A1 (en) 2013-11-28
IL261869A (en) 2018-10-31
RU2696575C2 (en) 2019-08-05
KR102131601B1 (en) 2020-07-09
EP2854882B1 (en) 2018-10-31
JP2015517388A (en) 2015-06-22
IL235549A0 (en) 2015-01-29
EP3466455B1 (en) 2022-01-19
RU2014152706A (en) 2016-07-20
BR112014029206B1 (en) 2019-11-26
IL261869B (en) 2020-07-30
KR102254305B1 (en) 2021-05-24
MX354596B (en) 2018-03-12
CN104321085A (en) 2015-01-28
BR122019014998B1 (en) 2020-01-28
RU2017128652A3 (en) 2019-05-28
EP3466455A1 (en) 2019-04-10
KR20150015517A (en) 2015-02-10
RU2629199C2 (en) 2017-08-25
CA3094664A1 (en) 2013-11-28
US20140329769A1 (en) 2014-11-06
US8815832B2 (en) 2014-08-26
ES2702714T3 (en) 2019-03-05
US20130316974A1 (en) 2013-11-28
US9539358B2 (en) 2017-01-10
AU2013266416B2 (en) 2016-03-24
EP4043042A1 (en) 2022-08-17
CA2874622C (en) 2021-03-09
CN104321085B (en) 2017-06-23
IL235549B (en) 2020-03-31
WO2013177242A1 (en) 2013-11-28
KR20200085904A (en) 2020-07-15
RU2017128652A (en) 2019-02-04
DK3466455T3 (en) 2022-03-14
AU2013266416A1 (en) 2014-11-27
JP6165849B2 (en) 2017-07-19

Similar Documents

Publication Publication Date Title
MX2014014322A (en) Oxidized regenerated cellulose hemostatic powders and methods of making.
ZA202209414B (en) Insect products and methods of manufacture and use thereof
MY179872A (en) Method for the production of commercial nanoparticle and microparticle powders
PH12013500632A1 (en) Smoke filters for smoking devices with porous masses having a carbon particle loading and an encapsulated pressure drop
MY169154A (en) Tobacco material, tobacco product to which tobacco material is added, and method for producing tobacco material
MX2016008158A (en) Methods for shaping fibrous material and treatment compositions therefor.
MX2016008161A (en) Methods for shaping fibrous material and treatment compositions therefor.
MX2016010373A (en) Rapamycin for the treatment of lymphangioleiomyomatosis.
MX2015013845A (en) Tiotropium dry powders.
PH12015502535A1 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
NZ630367A (en) Methods of treatment of pediatric solid tumor
UA110845C2 (en) Method for preparing adsorbent particles carrying flavoring
MY169808A (en) Plant powder-containing white chocolate-impregnated food and method for producing same
PH12017501546A1 (en) Dispersible dosage form
AU2013241750A8 (en) Nanoparticle aggregates containing osteopontin and calcium- and/or strontium-containing particles
MX346803B (en) Fine powder of biosourced aliphatic polyester and production method thereof.
MX2018003288A (en) System and method for controlling the harshness of nicotine-based dry powder formulations.
NZ706983A (en) Treating soluble coffee
WO2011089130A3 (en) Method for producing hollow bodies having enclosed freely displaceable particles
MY183106A (en) Fine dry particulate retinoid active agent compostions and topical formulations including the same
MY190070A (en) Method for producing a highly porous fine powdered slaked lime composition, and product obtained therefrom
MX2011011157A (en) Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of at least one cosmetic or pharmaceutical agent.
MX354460B (en) Encapsulation of extract in porous particles.
EP3357482A4 (en) Composite powder in which porous polymer is impregnated with scoria powder particles, cosmetic composition containing same, and process for producing same
MX2014011123A (en) Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles.

Legal Events

Date Code Title Description
FG Grant or registration